drugset / Trial / NCT03560232

Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens

NCT03560232

Phase 4 Terminated 17 enrolled Mercy Health Ohio
RandomizedParallel-groupOpen-labelPrevention

Summary

To demonstrate noninferiority of three different empiric antimicrobial regimens compared to the traditional antimicrobial regimen for the management of grade III open fractures as well as evaluate outcomes among these groups.

Timeline

Start
2018-07-09
Primary completion
2020-02-19
Completion
2020-02-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ampicillin/sulbactam Unknown 3 g Intravenous
Comparator Cefazolin Small molecule 2 g Intravenous
Comparator Ceftriaxone Other / unclassified 2 g Intravenous
Subject Clindamycin Unknown 600 mg Intravenous
Comparator Gentamicin Small molecule 3 mg/kg
Comparator Gentamicin Small molecule 5 mg/kg
Comparator Piperacillin/tazobactam Unknown 3.375 g Intravenous

Indications

No indication recorded.